Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide
SSX2IP
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN984472
Quick Overview for Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP) Peptide (ABIN984472)
Target
SSX2IP
(Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SSX2IP antibody (Catalog #: ARP53690_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SSX2IP (Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
-
Background
-
SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.
Alias Symbols: ADIP, FLJ10848, KIAA0923, MGC75026
Protein Interaction Partner: ACTN1,ACTN2,MLLT4,SSX2,SSX2IP,SSX3,ACTN1,MLLT4,USP11
Protein Size: 614 -
Molecular Weight
- 68 kDa
-
Gene ID
- 117178
-
NCBI Accession
- NM_014021, NP_054740
-
UniProt
- Q9Y2D8
Target
-
You are here:
